Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex

Autor: Trifan, G., Goldenberg, F.D., Caprio, F.Z., Biller, J., Schneck, M., Khaja, A., Terna, T., Brorson, J., Lazaridis, C., Bulwa, Z., Alvarado Dyer, R., Saleh Velez, F.G., Prabhakaran, S., Liotta, E.M., Batra, A., Reish, N.J., Ruland, S., Teitcher, M., Taylor, W., De la Pena, P., Conners, J.J., Grewal, P.K., Pinna, P., Dafer, R.M., Osteraas, N.D., DaSilva, I., Hall, J.P., John, S., Shafi, N., Miller, K., Moustafa, B., Vargas, A., Gorelick, P.B., Testai, F.D.

Publikováno v: In Journal of Stroke and Cerebrovascular Diseases November 2020 29(11)

Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation – safety, efficacy, and patient adherence

Autor: Lloret MJ, Ruiz-García C, DaSilva I, Furlano M, Barreiro Y, Ballarín J, Bover J

Publikováno v: Patient Preference and Adherence, Vol 2013, Iss default, Pp 1147-1156 (2013)

MªJesús Lloret, César Ruiz-García, Iara DaSilva, Mónica Furlano, Yaima Barreiro, José Ballarín, Jordi Bover Nephrology Department, Fundació Puigvert, IIB Sant Pau, Barcelona, Spain; REDinREN, Instituto de Investigación Carlos III, Madrid, Sp

Externí odkaz: https://doaj.org/article/bc698d21e7614ee589a5642972a77097

Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications

Autor: Bover J, Ureña-Torres P, Laiz Alonso AM, Torregrosa JV, Rodríguez-García M, Castro-Alonso C, Górriz JL, Benito S, López-Báez V, Lloret Cora MJ, Cigarrán S, DaSilva I, Sánchez-Bayá M, Mateu Escudero S, Guirado L, Cannata-Andía J

Publikováno v: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
NEFROLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica

Osteoporosis (OP) and chronic kidney disease (CKD) both independently affect bone health. A significant number of patients with CKD have decreased bone mineral density (BMD), are at high risk of fragility fractures and have an increased morbidity and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a34f3e8153417e1f275dfd45429bdee2
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2860

Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders

Autor: Bover, J, Urena, P, Aguilar, A, Mazzaferro, S, Benito, S, Lopez-Baez, V, Ramos, A, daSilva, I, Cozzolino, M

Publikováno v: CALCIFIED TISSUE INTERNATIONAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Alkaline phosphatases (APs) remove the phosphate (dephosphorylation) needed in multiple metabolic processes (from many molecules such as proteins, nucleotides, or pyrophosphate). Therefore, APs are important for bone mineralization but paradoxically

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::eb2a7771f84ac35f165ffce9eedb916d
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3459

Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?

Autor: Bover J, Górriz JL, Ureña-Torres P, Lloret MJ, Ruiz-García C, daSilva I, Chang P, Rodríguez M, Ballarín J

Publikováno v: NEFROLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Chronic kidney disease (CKD) has been used as a model and source of knowledge concerning the mechanisms, clinical relevance and accelerated progression of cardiovascular (CV) calcification, as well as its consequences in clinical practice, despite we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::45f89426fb77f24428680e994ef37f0f
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1362